Login / Signup
Li Wang
ORCID
Publication Activity (10 Years)
Years Active: 2019-2024
Publications (10 Years): 2
Top Topics
Locally Advanced
Randomized Controlled Trial
Squamous Cell
Open Label
Top Venues
Journal of gynecologic oncology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Xiaohua Wu
,
Jihong Liu
,
Ruifang An
,
Rutie Yin
,
Yu Zhang
,
Huaijun Zhou
,
Aiqin He
,
Li Wang
,
Jieqing Zhang
,
Ziling Liu
,
Wei Duan
,
Jian Qing Zhu
,
Ge Lou
,
Guilin Chen
,
Ying Cheng
,
Fengxia Xue
,
Sonja Nick
,
Haiyan Wang
,
Donghang Li
First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trial.
Journal of gynecologic oncology
(2024)
Yan Xiao
,
Huijun Cheng
,
Li Wang
,
Xiao Yu
Clinical response and safety of apatinib monotherapy in recurrent, metastatic cervical cancer after failure of chemotherapy: a retrospective study.
Journal of gynecologic oncology
31 (1) (2019)